Who owns AVADEL PHARMACEUTICALS PLC COM SHS?
- Ticker: AVDL
- CUSIP Number: g29687103
Tip: Access positions for across all investors
Analyze quarterly positions in Avadel Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Avadel Pharmaceuticals stock
Who bought or sold AVADEL PHARMACEUTICALS PLC COM SHS this quarter?
There are no current stakeholders of Avadel Pharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Avadel Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| State Street Corporation | Dec 2025 | 2.3M | $49M |
| Highbridge Capital Management | Dec 2025 | 2.0M | $44M |
| Morgan Stanley | Dec 2025 | 529k | $11M |
| T. Rowe Price Associates | Dec 2025 | 52k | $1.1M |
| Us Bancorp | Dec 2025 | 19k | $408k |
| Burns Wealth Management | Dec 2025 | 11k | $238k |
| CWM | Dec 2025 | 2.6k | $55k |
| Cherry Tree Wealth Management | Dec 2025 | 300.00 | $6.5k |
| IFP Advisors | Mar 2026 | 20.00 | $426.000000 |